Mangiferin Alleviates Formaldehyde‐Induced Tau Hyperphosphorylation and Cognitive Impairment in Mice via the PI3K/AKT/GSK3β Pathway: Insights From Network Pharmacology and Experimental Validation
The FASEB Journal · 2026
DOI: 10.1096/fj.202503159r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Na Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Brain and Cognitive Science, School of Basic Medical Sciences, Dali University, Dali, Yunnan, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Glycogen Synthase Kinase 3 beta, Phosphatidylinositol 3-Kinases, Formaldehyde. Die Arbeit nennt 58 Literaturangaben. Gefördert von: Yunnan Fundamental Research Projects.
Abstract (Originalsprache)
Studies have demonstrated that accumulation of formaldehyde (FA) in the body can result in Alzheimer's disease (AD) like changes including cognitive impairment, Aβ deposition, and Tau hyperphosphorylation. Mangiferin (MGF), a natural flavonoid compound, has been suggested in previous reports to have potential in the treatment of AD. This study integrated network pharmacology and in vivo experiments to elucidate the therapeutic potential and mechanisms of MGF in mitigating FA‐induced neurotoxicity. Potential overlapping targets between MGF and AD were identified using jvenn. Functional enrichment analysis of these targets was performed with DAVID. A protein–protein interaction (PPI) network was constructed using STRING and visualized in Cytoscape to identify hub genes. Molecular docking simulations with AutoDock were then employed to assess binding affinity. Subsequently, for experimental validation, a mouse model of FA‐induced neurotoxicity was established. Spatial memory and cognitive function in mice were evaluated using the Y‐maze and novel object recognition tests. The expression levels of key pathway‐related proteins in the cortex and hippocampus were analyzed via immunohistochemistry (IHC) and Western blotting (WB). Network analysis identified AKT1 and GSK3β as key targets, and molecular docking confirmed strong binding affinity between MGF and these proteins. Experimental validation demonstrated that MGF dose‐dependently improved spatial memory and cognitive performance in FA‐exposed mice, reduced neuronal apoptosis, and suppressed Tau hyperphosphorylation at Thr181, Ser396, and Ser404. Mechanistically, MGF activated the PI3K/AKT pathway, leading to GSK3β inactivation through Ser9 phosphorylation. These findings highlight MGF as a promising therapeutic candidate for AD by targeting the PI3K/AKT/GSK3β axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Brain and Cognitive Science, School of Basic Medical Sciences, Dali University, Dali, Yunnan, China.
- School of Medical Laboratory, Northern Henan Medical University, Xinxiang, Henan, China.
- The Affiliated Mental Health Center of Jiangnan University, Wuxi, Jiangsu, China.
- Laboratory of Heart Disease Mechanism and Translational Research, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
ORCID-Profile: Na Wang
Förderung
- Yunnan Fundamental Research Projects
Zitieren
APA
Wang, N., Sun, Z., Chen, F., Tian, X., Li, J., & He, X. (2026). Mangiferin Alleviates Formaldehyde‐Induced Tau Hyperphosphorylation and Cognitive Impairment in Mice via the PI3K/AKT/GSK3β Pathway: Insights From Network Pharmacology and Experimental Validation. The FASEB Journal. https://doi.org/10.1096/fj.202503159r
Vancouver
Wang N, Sun Z, Chen F, Tian X, Li J, He X. Mangiferin Alleviates Formaldehyde‐Induced Tau Hyperphosphorylation and Cognitive Impairment in Mice via the PI3K/AKT/GSK3β Pathway: Insights From Network Pharmacology and Experimental Validation. The FASEB Journal. 2026. doi:10.1096/fj.202503159r
BibTeX
@article{Wang2026,
author = {Wang, Na and Sun, Ziteng and Chen, Fan and Tian, Xinyan and Li, Juan and He, Xiaping},
title = {Mangiferin Alleviates Formaldehyde‐Induced Tau Hyperphosphorylation and Cognitive Impairment in Mice via the PI3K/AKT/GSK3β Pathway: Insights From Network Pharmacology and Experimental Validation},
journal = {The FASEB Journal},
year = {2026},
doi = {10.1096/fj.202503159r}
}
EUVIMED